[1]
SREE, K.J. et al. 2025. QBD-BASED RP-UPLC METHOD DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS ESTIMATION OF ATEZOLIZUMAB AND HYALURONIDASE IN CANCER DRUG FORMULATIONS. International Journal of Applied Pharmaceutics. 17, 5 (Sep. 2025), 406–416. DOI:https://doi.org/10.22159/ijap.2025v17i5.54200.